NM_000500.9:c.69G>T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PM1PP2BP4_Strong
The NM_000500.9(CYP21A2):c.69G>T(p.Trp23Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000509 in 1,591,562 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00046 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 1 hom. )
Consequence
CYP21A2
NM_000500.9 missense
NM_000500.9 missense
Scores
7
11
Clinical Significance
Conservation
PhyloP100: 1.91
Publications
5 publications found
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 Gene-Disease associations (from GenCC):
- classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting formInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing formInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_000500.9
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 52 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Trascript score misZ: 1.8021 (below the threshold of 3.09). GenCC associations: The gene is linked to classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form.
BP4
Computational evidence support a benign effect (MetaRNN=0.04066196).
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP21A2 | NM_000500.9 | c.69G>T | p.Trp23Cys | missense_variant | Exon 1 of 10 | ENST00000644719.2 | NP_000491.4 | |
| CYP21A2 | NM_001128590.4 | c.69G>T | p.Trp23Cys | missense_variant | Exon 1 of 9 | NP_001122062.3 | ||
| CYP21A2 | NM_001368143.2 | c.-356G>T | 5_prime_UTR_variant | Exon 1 of 10 | NP_001355072.1 | |||
| CYP21A2 | NM_001368144.2 | c.-266G>T | 5_prime_UTR_variant | Exon 1 of 9 | NP_001355073.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152094Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
70
AN:
152094
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000546 AC: 115AN: 210526 AF XY: 0.000584 show subpopulations
GnomAD2 exomes
AF:
AC:
115
AN:
210526
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000514 AC: 740AN: 1439350Hom.: 1 Cov.: 104 AF XY: 0.000522 AC XY: 373AN XY: 714210 show subpopulations
GnomAD4 exome
AF:
AC:
740
AN:
1439350
Hom.:
Cov.:
104
AF XY:
AC XY:
373
AN XY:
714210
show subpopulations
African (AFR)
AF:
AC:
2
AN:
32858
American (AMR)
AF:
AC:
25
AN:
41628
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25748
East Asian (EAS)
AF:
AC:
0
AN:
38776
South Asian (SAS)
AF:
AC:
0
AN:
83742
European-Finnish (FIN)
AF:
AC:
1
AN:
50826
Middle Eastern (MID)
AF:
AC:
0
AN:
5676
European-Non Finnish (NFE)
AF:
AC:
686
AN:
1100548
Other (OTH)
AF:
AC:
26
AN:
59548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.653
Heterozygous variant carriers
0
67
134
200
267
334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000460 AC: 70AN: 152212Hom.: 1 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
70
AN:
152212
Hom.:
Cov.:
33
AF XY:
AC XY:
30
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
7
AN:
41552
American (AMR)
AF:
AC:
10
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5144
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52
AN:
67990
Other (OTH)
AF:
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.663
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
43
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Apr 19, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Uncertain:1
Aug 14, 2024
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
DEOGEN2
Benign
.;.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;.;D;D;.;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D;D;.
REVEL
Uncertain
Sift
Uncertain
D;.;D;D;D;.
Sift4G
Benign
T;.;D;D;T;.
Polyphen
D;D;.;.;.;D
Vest4
MutPred
Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);Gain of catalytic residue at W23 (P = 0.026);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.